EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity

Atle Bråthen Pentz, Clara Maria Fides Timpe, Elizabeth Marie Normann, Nora Berz Slapø, Ingrid Melle, Trine Vik Lagerberg, Nils Eiel Steen, Lars T Westlye, Erik G Jönsson, Unn K Haukvik, Torgeir Moberget, Ole A Andreassen und 1 weitere

Schizophrenia Research · 2023-11 · 261 · 80-93

DOI: 10.1016/j.schres.2023.09.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Research, 2023-11. Verfasst von Atle Bråthen Pentz und 12 weiteren Autor:innen. Beteiligte Einrichtung: NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway. Electronic a…. Hauptthemen laut MEDLINE: Bipolar Disorder, Schizophrenia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Centre for Digital Life Norway, University Hospitals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Research increasingly implicates glutamatergic dysfunction in the pathophysiologies of psychotic disorders. Auditory mismatch negativity (MMN) is an electroencephalography (EEG) waveform linked to glutamatergic neurotransmission and is consistently attenuated in schizophrenia (SCZ). MMN consists of two subcomponents, the repetition positivity (RP) and deviant negativity (DN) possibly reflecting different neural mechanisms. However, whether MMN reduction is present across different psychotic disorders, linked to distinct symptom clusters, or related to sex remain to be clarified. METHODS: Four hundred participants including healthy controls (HCs; n = 296) and individuals with SCZ (n = 39), bipolar disorder (BD) BD typeI (n = 35), or BD type II (n = 30) underwent a roving MMN paradigm and clinical evaluation. MMN, RP and DN as well their memory traces were recorded at the FCZ electrode. Analyses of variance and linear regression models were used both transdiagnostically and within clinical groups. RESULTS: MMN was reduced in SCZ compared to BD (p = 0.006, d = 0.55) and to HCs (p < 0.001, d = 0.63). There was a significant group × sex interaction (p < 0.003) and the MMN impairment was only detected in males with SCZ. MMN amplitude correlated positively with Positive and Negative Syndrome Scale total score and negatively with Global Assessment of Functioning Scale score. The deviant negativity was impaired in males with SCZ. No group differences in memory trace indices of the MMN, DN, or RP. CONCLUSION: MMN was attenuated in SCZ and correlated with greater severity of psychotic symptoms and lower level of functioning. Our results may indicate sex-dependent differences of glutamatergic function in SCZ.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderSchizophreniaHumansMaleFemaleEvoked Potentials, AuditorySex CharacteristicsElectroencephalography

Stichwörter der Autor:innen

Bipolar disorder type IBipolar disorder type IIMismatch negativitySchizophrenia

Autor:innen und Institutionen

  • NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway. Electronic address: atle.pentz@medisin.uio.no.
  • NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway; Department of Psychology, University of Oslo, Oslo, Norway.
  • University of Copenhagen, Copenhagen, Denmark.
  • NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway.
  • NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • NORMENT, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Norway; Centre for Psychiatric Research, Department of Clinical Neuroscience, Karolinska I…

Förderung

  • European Research Council
  • Centre for Digital Life Norway
  • University Hospitals
  • Norges Forskningsråd
  • Helse Sør-Øst RHF
  • Horizon 2020

Zitieren

APA

Pentz, A. B., Timpe, C. M. F., Normann, E. M., Slapø, N. B., Melle, I., Lagerberg, T. V., Steen, N. E., Westlye, L. T., Jönsson, E. G., Haukvik, U. K., Moberget, T., Andreassen, O. A., & Elvsåshagen, T. (2023). Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity. Schizophrenia Research, 261, 80-93. https://doi.org/10.1016/j.schres.2023.09.012

Vancouver

Pentz AB, Timpe CMF, Normann EM, Slapø NB, Melle I, Lagerberg TV, et al. Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity. Schizophrenia Research. 2023;261:80-93. doi:10.1016/j.schres.2023.09.012

BibTeX
@article{Pentz2023,
  author = {Pentz, Atle Bråthen and Timpe, Clara Maria Fides and Normann, Elizabeth Marie and Slapø, Nora Berz and Melle, Ingrid and Lagerberg, Trine Vik and Steen, Nils Eiel and Westlye, Lars T and Jönsson, Erik G and Haukvik, Unn K and Moberget, Torgeir and Andreassen, Ole A and Elvsåshagen, Torbjørn},
  title = {Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity},
  journal = {Schizophrenia Research},
  year = {2023},
  volume = {261},
  pages = {80--93},
  doi = {10.1016/j.schres.2023.09.012}
}
Kostenlos starten →